FDA Inspection 1118196 — Novo Nordisk A/S - 25A-B

Novo Nordisk A/S - 25A-B — FEI 3003131673

The FDA completed an inspection of Novo Nordisk A/S - 25A-B on Jun 14, 2018 in Hillerod. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hillerod (Denmark)

Additional Details

Mutual Recognition Agreement (MRA)